Why 90% of clinical drug development fails and how to improve it?

Sun, Duxin, Gao, Wei, Hu, Hongxiang, Zhou, Simon·2022·Acta Pharmaceutica Sinica B
DOI 10.1016/j.apsb.2022.02.002

Cited by (1,000)

Items 101–200 of 1,000

  1. Modernizing Preclinical Drug Development: The Role of New Approach Methodologies
    Krina Mehta, Christian Maaß, L. Cucurull-Sanchez, César Pichardo‐Almarza, Kalyanasundaram Subramanian, Ioannis P. Androulakis, Jogarao V. S. Gobburu, Stephan Schaller, Catherine M.T. Sherwin · 2025 · ACS Pharmacology & Translational Science
  2. New clinical application prospects of artemisinin and its derivatives: a scoping review
    Yangmu Huang, Yang Yang, Guangqi Liu, Ming Xu · 2023 · Infectious Diseases of Poverty
  3. Utilization of 3D bioprinting technology in creating human tissue and organoid models for preclinical drug research – State-of-the-art
    Joachim Frankowski, Matylda Kurzątkowska, Marcin Sobczak, Urszula Piotrowska · 2023 · International Journal of Pharmaceutics
  4. Historical Perspective and Current Trends in Anticancer Drug Development
    Katarzyna Gach, Joanna Drogosz-Stachowicz, Anna Ewa Janecka, Karol Wtorek, Marek Mirowski · 2024 · Cancers
  5. The rat as an animal model in chronic wound research: An update
    Mahboubeh Ghanbari, Yury Salkovskiy, Mark A. Carlson · 2024 · Life Sciences
  6. Radioactive ADME Demonstrates ARV-110’s High Druggability Despite Low Oral Bioavailability
    Yifei He, Yuandong Zheng, Chenggu Zhu, Lei Peng, Jinghua Yu, Chongzhuang Tang, Hao Chen, Xingxing Diao · 2024 · Journal of Medicinal Chemistry
  7. Modeling protein–ligand interactions for drug discovery in the era of deep learning
    Y.X. Wang, Yibo Li, Jiaxiao Chen, Luhua Lai · 2025 · Chemical Society Reviews
  8. Synthesis of β-acids loaded chitosan-sodium tripolyphosphate nanoparticle towards controlled release, antibacterial and anticancer activity
    Bingren Tian, Xia Qiao, Songlin Guo, Aiqin Li, Yanan Xu, Jia Cao, Xu Zhang, Duan Ma · 2023 · International Journal of Biological Macromolecules
  9. Progress on drug nanoparticle manufacturing: exploring the adaptability of batch bottom-up approaches to continuous manufacturing
    Clarinda Costa, Luís Padrela · 2025 · Journal of Drug Delivery Science and Technology
  10. D-Limonene Promotes Anti-Obesity in 3T3-L1 Adipocytes and High-Calorie Diet-Induced Obese Rats by Activating the AMPK Signaling Pathway
    Jin-Ting Liao, Yu-Wen Huang, Chih‐Yao Hou, Jyh‐Jye Wang, Chih‐Chung Wu, Shu‐Ling Hsieh · 2023 · Nutrients
  11. Human vascularised synovium-on-a-chip: a mechanically stimulated, microfluidic model to investigate synovial inflammation and monocyte recruitment
    Clare L. Thompson, Timothy Hopkins, Catrin Bevan, Hazel R. C. Screen, Karina Therese Wright, Martin M. Knight · 2023 · Biomedical Materials
  12. In silico off-target profiling for enhanced drug safety assessment
    Jin Liu, Yike Gui, Jingxin Rao, Jingjing Sun, Gang Wang, Qun Ren, Ning Qu, Buying Niu, Zhiyi Chen, Xia Sheng et al. · 2024 · Acta Pharmaceutica Sinica B
  13. Exploring Deep Eutectic Solvents as Pharmaceutical Excipients: Enhancing the Solubility of Ibuprofen and Mefenamic Acid
    Mihaela-Alexandra Nica, Valentina Anuța, Cristian Andi Nicolae, Lăcrămioara Popa, Mihaela Violeta Ghica, Florentina-Iuliana Cocoș, Cristina‐Elena Dinu‐Pîrvu · 2024 · Pharmaceuticals
  14. Synergistic combinations of antimicrobial peptides and conventional antibiotics: A strategy to delay resistance emergence in World Health Organization priority bacteria
    Cesar Augusto Roque‐Borda, Qi Zhang, Thi Phuong Truc Nguyen, Thi Thu Hoai Nguyen, Himadri Medhi, Heitor Leocádio de Souza Rodrigues, Christian Shleider Carnero Canales, Darcy Sutherland, Naiera M. Helmy, Prasanna Babu Araveti et al. · 2025 · Pharmacological Reviews
  15. The OREGANO knowledge graph for computational drug repurposing
    Marina Boudin, Gayo Diallo, Martin Drancé, Fleur Mougin A · 2023 · Scientific Data
  16. Microfluidic Liver-on-a-Chip for Preclinical Drug Discovery
    Fu, Jingyu, Qiu, Hailong, Tan, Cherie S. · 2023 · Pharmaceutics
  17. Why Animal Experiments Are Still Indispensable in Bone Research: A Statement by the European Calcified Tissue Society
    Stein, Merle, Elefteriou, Florent, Busse, Björn, Fiedler, Imke AK, Kwon, Ronald Young, Farrell, Eric, Ahmad, Mubashir, Ignatius, Anita, Grover, Liam, Geris, Liesbet et al. · 2023 · Journal of Bone and Mineral Research
  18. Recent Studies of Artificial Intelligence on In Silico Drug Distribution Prediction
    Thi Tuyet Van Tran, Hilal Tayara, Kil To Chong · 2023 · International Journal of Molecular Sciences
  19. Pluripotent stem cell-derived models of retinal disease: Elucidating pathogenesis, evaluating novel treatments, and estimating toxicity
    Marzena Kurzawa‐Akanbi, Nikolaos Tzoumas, Julio C. Corral-Serrano, Rosellina Guarascio, DAVID H. STEEL, Michael E. Cheetham, Lyle Armstrong, Majlinda Lako · 2024 · Progress in Retinal and Eye Research
  20. Another string to your bow: machine learning prediction of the pharmacokinetic properties of small molecules
    Davide Bassani, Neil John Parrott, Nenad Manevski, Jitao David Zhang · 2024 · Expert Opinion on Drug Discovery
  21. Application of machine learning in drug side effect prediction: databases, methods, and challenges
    Haochen Zhao, Jian Zhong, Xiao Liang, Chenliang Xie, Shaokai Wang · 2024 · Frontiers of Computer Science
  22. What Are the Reasons for Continuing Failures in Cancer Therapy? Are Misleading/Inappropriate Preclinical Assays to Be Blamed? Might Some Modern Therapies Cause More Harm than Benefit?
    Razmik Mirzayans, David L. Murray · 2022 · International Journal of Molecular Sciences
  23. Drug–disease association prediction with literature based multi-feature fusion
    Hongyu Kang, Li Hou, Yaowen Gu, Xiao Ting Lu, Jiao Li, Qin Li · 2023 · Frontiers in Pharmacology
  24. The use of artificial intelligence in the treatment of rare diseases: A scoping review
    Da He, Ru Wang, Zhilin Xu, Jiangna Wang, Peipei Song, Haiyin Wang, Jinying Su · 2023 · Intractable & Rare Diseases Research
  25. How can quantum computing be applied in clinical trial design and optimization?
    Hakan Doğa, Aritra Bose, M. Emre Sahin, Joao H. Bettencourt‐Silva, Anh Pham, Eunyoung Kim, Alan Andress, Sudhir Saxena, Laxmi Parida, Jan Lukas Robertus et al. · 2024 · Trends in Pharmacological Sciences
  26. Grand challenges in industrial and systems engineering
    Waldemar Karwowski, Gavriel Salvendy, Laura A. Albert, Woo Chang Kim, Brian T. Denton, Maged M. Dessouky, Alexandre B. Dolgui, Vincent G. Duffy, Soundar R. T. Kumara, Jingshan Li et al. · 2025 · International Journal of Production Research
  27. Advances of dual-organ and multi-organ systems for gut, lung, skin and liver models in absorption and metabolism studies
    Konstanze Brandauer, Sophie Schweinitzer, Alexandra Lorenz, Judith Krauß, Silvia Schobesberger, Martin Frauenlob, Peter Ertl · 2025 · Lab on a Chip
  28. Unlocking the therapeutic potential of cellular mechanobiology
    Yohalie Kalukula, Giuseppe Ciccone, Danahé Mohammed, Anthony Procès, Marie Versaevel, Amandine Deridoux, Lucie Ergot, Zoé Barbier, Mina Mansy, Roxane Aucouturier et al. · 2025 · Science Advances
  29. Engineering brain-on-a-chip platforms
    Bram Servais, Negar Mahmoudi, Vini Gautam, Wei Tong, Michael R. Ibbotson, David R. Nisbet, David J. Collins · 2024 · Nature Reviews Bioengineering
  30. Employing Automated Machine Learning (AutoML) Methods to Facilitate the In Silico ADMET Properties Prediction
    Herim Han, Bilal Shaker, Jin Hee Lee, Sunghwan Choi, Sang-Hee Yoon, Maninder Singh, Shaherin Basith, Minghua Cui, Sunil Ahn, Junyoung An et al. · 2025 · Journal of Chemical Information and Modeling
  31. Perspectives on Ligand/Protein Binding Kinetics Simulations: Force Fields, Machine Learning, Sampling, and User-Friendliness
    Paolo Conflitti, Stefano Raniolo, Vittorio Limongelli · 2023 · Journal of Chemical Theory and Computation
  32. Benchmarking of Small Molecule Feature Representations for hERG, Nav1.5, and Cav1.2 Cardiotoxicity Prediction
    Issar Arab, Kristof Egghe, Kris Laukens, Ke Chen, Khaled Barakat, Wout Bittremieux · 2023 · Journal of Chemical Information and Modeling
  33. Genome-wide pan-GPCR cell libraries accelerate drug discovery
    Hanting Yang, Yongfu Wang, Wei Liu, Taiping He, Jia‐Yu Liao, Zhong‐Zhi Qian, Jing‐Hao Zhao, Zhaotong Cong, Dan Sun, Zhixiang Liu et al. · 2024 · Acta Pharmaceutica Sinica B
  34. Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps
    Valeria Gigante, Richard A. Alm, Daniela Melchiorri, Tamarie Pearl Rocke, César A. Arias, Lloyd G. Czaplewski, PRABHAVATHI B. FERNANDES, Francois J. Franceschi, Stephan Harbarth, Roman Sergeevich Kozlov et al. · 2024 · Antimicrobial Agents and Chemotherapy
  35. Rapid Biofabrication of an Advanced Microphysiological System Mimicking Phenotypical Heterogeneity and Drug Resistance in Glioblastoma
    Sirjana Pun, Anusha Prakash, Dalee Demaree, Daniel Pomeranz Krummel, Giuseppe Sciumè, Soma Sengupta, Riccardo Barrile · 2024 · Advanced Healthcare Materials
  36. Animal models in neuroscience with alternative approaches: Evolutionary, biomedical, and ethical perspectives
    Sabina Neziri, Ahmet Efe Köseoğlu, Gülsüm Deniz Köseoğlu, Buminhan Özgültekin, Nehir Özdemir Özgentürk · 2024 · Animal Models and Experimental Medicine
  37. Generative AI: driving productivity and scientific breakthroughs in pharmaceutical R&D
    Guy Doron, Sam Genway, Mark Roberts, Sai Jasti · 2024 · Drug Discovery Today
  38. Liver-on-a-chip: Considerations, advances, and beyond
    Zhenxu Yang, Xiaochen Liu, Elise M. Cribbin, Alice M. Kim, Jiao Jiao Li, Ken‐Tye Yong · 2022 · Biomicrofluidics
  39. IUPHAR review: Navigating the role of preclinical models in pain research
    Seyed Asaad Karimi, Fatama Tuz Zahra, Loren J. Martin · 2024 · Pharmacological Research
  40. Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders
    Irina S. Balan, Giorgia Boero, Samantha Lucenell Chéry, Minna H. McFarland, Alejandro G. Lopez, A. Leslie Morrow · 2024 · Life
  41. Skin-on-a-chip technologies towards clinical translation and commercialization
    Nilufar Ismayilzada, Ceren Tarar, Sajjad Rahmani Dabbagh, Begüm Kübra Tokyay, Sara Asghari Dilmani, Emel Sokullu, Hasan Erbil Abaci, Savaş Taşoğlu · 2024 · Biofabrication
  42. Neonatal encephalopathy due to suspected hypoxic ischemic encephalopathy: pathophysiology, current, and emerging treatments
    Carina Corte-Real Babbo, Juanita Mellet, Janse van Rensburg, Shakti Pillay, Alan R. Horn, Firdose Lambey Nakwa, Sithembiso Velaphi, Gugulabatembunamahlubi Tenjiwe Jabulile Kali, M Coetzee, Mogomane Yvonne Khomotso Masemola et al. · 2024 · World Journal of Pediatrics
  43. Semaglutide Ameliorates Diabetic Neuropathic Pain by Inhibiting Neuroinflammation in the Spinal Cord
    Sing-Ong Lee, Yaswanth Kuthati, Wei-Hsiu Huang, Chih‐Shung Wong · 2024 · Cells
  44. AI-directed formulation strategy design initiates rational drug development
    Nannan Wang, Jie Dong, Defang Ouyang · 2024 · Journal of Controlled Release
  45. Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs – a more refined perspective
    Z. Jenei-Lanzl, Svenja Maurer, Rolf E. Brenner, F. Zaucke, Michael Fuchs, J. Riegger · 2025 · Archives of pharmacal research
  46. Regulated Induced Proximity Targeting Chimeras (RIPTACs): a Novel Heterobifunctional Small Molecule Therapeutic Strategy for Killing Cancer Cells Selectively
    Kanak Raina, Chris D. Forbes, Rebecca Stronk, Jonathan P. Rappi, Kyle J. Eastman, Samuel W. Gerritz, Xinheng Yu, Hao Li, Amit Bhardwaj, Mia Forgione et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  47. Nanoparticle-based delivery systems as emerging therapy in retinoblastoma: recent advances, challenges and prospects
    Adaeze Linda Onugwu, Onyinyechi Lydia Ugorji, Chinasa A Ufondu, Stella Amarachi Ihim, Adaeze Chidiebere Echezona, Chinekwu Sherridan Nwagwu, Sabastine Obinna Onugwu, Samuel Wisdom Uzondu, Chinazom Precious Agbo, John Dike Ogbonna et al. · 2023 · Nanoscale Advances
  48. Development and validation of PAMPA-BBB QSAR model to predict brain penetration potential of novel drug candidates
    Rintaro Kato, Wenyu Zeng, Vishal B. Siramshetty, J. W. Williams, Md Kabir, Natalie R. Hagen, Elias Carvalho Padilha, Amy Q. Wang, Ewy A. Mathé, Xin Xu et al. · 2023 · Frontiers in Pharmacology
  49. Approaches, Strategies and Procedures for Identifying Anti-Inflammatory Drug Lead Molecules from Natural Products
    Tenzin Jamtsho, Karma Yeshi, Matthew J. Perry, Alex C. Loukas, Phurpa Wangchuk · 2024 · Pharmaceuticals
  50. The Clinical Translation of α-humulene – A Scoping Review
    Nishaanth Dalavaye, Martha Nicholas, Manaswini Pillai, Simon Erridge, Mikael Hans Sodergren · 2024 · Planta Medica
  51. Topical retinoid drug Adapalene: A new frontier in cancer treatment
    Shazia Sofi, Nusrat Jan, Umar Mehraj, Manzoor Ahmad Mir · 2024 · Results in Chemistry
  52. Quality by digital design to accelerate sustainable medicines development
    Chantal L. Mustoe, Alice Turner, Stephanie J. Urwin, Ian Houson, Helen Feilden, Daniel Markl, Mohammed M. Al Qaraghuli, Magdalene W. S. Chong, Murray N. Robertson, Alison Nordon et al. · 2025 · International Journal of Pharmaceutics
  53. A Comprehensive Review of Antimicrobial Agents Against Clinically Important Bacterial Pathogens: Prospects for Phytochemicals
    Ghosh, Soumyadip, Basu, Soumya, Anbarasu, Anand, Ramaiah, Sudha · 2025 · Phytotherapy Research
  54. Development of Antiepileptic Drugs throughout History: From Serendipity to Artificial Intelligence
    María Gabriela Corrales-Hernández, Sebastián Kurt Villarroel-Hagemann, Isabella Mendoza-Rodelo, Leonardo Palacios-Sánchez, Mariana Gaviria-Carrillo, Natalia Buitrago-Ricaurte, Santiago Espinosa-Lugo, Carlos‐Alberto Calderón‐Ospina, Jesús Hernán Rodríguez · 2023 · Biomedicines
  55. Cryo-electron microscopy-based drug design
    Ecenur Cebi, Joohyun Lee, Vinod Kumar Subramani, Nayeon Bak, Changsuk Oh, Kyeong Kyu Kim · 2024 · Frontiers in Molecular Biosciences
  56. Bioprinting of Perfusable Vascularized Organ Models for Drug Development via Sacrificial‐Free Direct Ink Writing
    Dongwei Wu, Shumin Pang, Johanna Berg, Yikun Mei, Ahmed S. M. Ali, Viola Röhrs, Beatrice Tolksdorf, Judith Hagenbuchner, Michael J. Ausserlechner, Hedwig E. Deubzer et al. · 2024 · Advanced Functional Materials
  57. Antibiotics: From Mechanism of Action to Resistance and Beyond
    Shyamalima Saikia, Pankaj Chetia · 2024 · Indian Journal of Microbiology
  58. Lubricant‐Coated Organ‐on‐a‐Chip for Enhanced Precision in Preclinical Drug Testing
    Tae Young Kim, Jeong‐Won Choi, Kijun Park, SeungHwan Kim, Jeong F. Kim, Tae‐Eun Park, Jungmok Seo · 2024 · Small
  59. Navigating the frontier of drug-like chemical space with cutting-edge generative AI models
    Antonio Lavecchia · 2024 · Drug Discovery Today
  60. Impact of Reductive Stress on Human Infertility: Underlying Mechanisms and Perspectives
    Efthalia Moustakli, Athanasios Zikopoulos, Charikleia Skentou, Periklis Katopodis, Ekaterini Domali, Anastasios Potiris, Sofoklis Stavros, Athanasios Zachariou · 2024 · International Journal of Molecular Sciences
  61. Bone-brain interaction: mechanisms and potential intervention strategies of biomaterials
    Jiaze Yu, Luli Ji, Yongxian Liu, Xiaogang Wang, Jing Wang, Changsheng Liu · 2025 · Bone Research
  62. AI-driven nanomedicine for cancer theranostics
    Ashutosh Tiwari, Widodo, Dyah Ika Krisnawati, Chih-Yu Chen, Tsung‐Rong Kuo · 2026 · Molecular Cancer
  63. New approach methodologies for drug discovery
    Wenqiang Liu, Paul D. Pang, Catherine A. Wu, Danilo A. Tagle, Joseph C. Wu · 2026 · Cell
  64. Endorsement of TNBC Biomarkers in Precision Therapy by Nanotechnology
    Aiswarya Chaudhuri, Dulla Naveen Kumar, Deepa Dehari, Rohit Patil, Sanjay Kumar Singh, Dinesh K. Kumar, Ashish Kumar Agrawal · 2023 · Cancers
  65. RIPTACs: A groundbreaking approach to drug discovery
    Zonghui Ma, Andrew A. Bolinger, Jia Zhou · 2023 · Drug Discovery Today
  66. The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation?
    Asia Marangio, Andrea Biccari, Edoardo D’Angelo, Francesca Sensi, Gaya Spolverato, Salvatore Pucciarelli, Marco Agostini · 2022 · Cancers
  67. Repurposing drugs targeting metabolic diseases for cancer therapeutics
    Pillai U, Jisha, Ray, Anindita, Maan, Meenu, Dutta, Mainak · 2023 · Drug Discovery Today
  68. Application of variational graph encoders as an effective generalist algorithm in computer-aided drug design
    Hilbert Yuen In Lam, Robbe Pincket, Hao Han, Xing Er Ong, Zechen Wang, Jamie Hinks, Yanjie Wei, Weifeng Li, Liangzhen Zheng, Yuguang Mu · 2023 · Nature Machine Intelligence
  69. The Role of Myeloperoxidase in Clozapine-Induced Inflammation: A Mechanistic Update for Idiosyncratic Drug-Induced Agranulocytosis
    Samantha Christine Sernoskie, Alison Jee, Jack Uetrecht · 2023 · International Journal of Molecular Sciences
  70. Unlocking the Potential of Camel Milk-Derived Exosomes as Novel Delivery Systems: Enhanced Bioavailability of ARV-825 PROTAC for Cancer Therapy
    Aakash Nathani, Mounika Aare, Li Jun Sun, Arvind Bagde, Yan Li, Arun K. Rishi, Mandip S. Singh · 2024 · Pharmaceutics
  71. Revitalizing the heart: strategies and tools for cardiomyocyte regeneration post-myocardial infarction
    Axelle Bois, Catarina Grandela, James Gallant, Christine L. Mummery, Philippe Menasché · 2025 · npj Regenerative Medicine
  72. Residence time in drug discovery: current insights and future perspectives
    Szymon K. Kordylewski, Ryszard Bugno, Sabina Podlewska · 2025 · Pharmacological Reports
  73. Cannabinoids and Chronic Liver Diseases
    Ralph‐Sydney Mboumba Bouassa, Giada Sebastiani, Vincenzo Di Marzo, Mohammad-Ali Jenabian, Cecilia Theresa Costiniuk · 2022 · International Journal of Molecular Sciences
  74. Drug Metabolism of Hepatocyte-like Organoids and Their Applicability in In Vitro Toxicity Testing
    Manon Bouwmeester, Yu Tao, Susana Proença, Frank G. van Steenbeek, Roos‐Anne Samsom, Sandra M. Nijmeijer, Theo L. Sinnige, Luc J. W. van der Laan, Juliette Legler, Kerstin Schneeberger et al. · 2023 · Molecules
  75. Gex2SGen: Designing Drug-like Molecules from Desired Gene Expression Signatures
    Dibyajyoti Das, Broto Chakrabarty, Rajgopal Srinivasan, Arijit Roy · 2023 · Journal of Chemical Information and Modeling
  76. The recent progress of deep-learning-based in silico prediction of drug combination
    Haoyang Liu, Zhiguang Fan, Jie Lin, Yuedong Yang, Ting Ran, Hongming Chen · 2023 · Drug Discovery Today
  77. Know your molecule: pharmacological characterization of drug candidates to enhance efficacy and reduce late-stage attrition
    Terry Kenakin · 2024 · Nature Reviews Drug Discovery
  78. Bioactives From Brown Algae: Antioxidant, Anti‐Inflammatory, Anticancer, and Antimicrobial Potential
    Irvin Fonseca‐Barahona, Kaveh Shahbaz, Saeid Baroutian · 2025 · ChemBioEng Reviews
  79. LivHeart: A Multi Organ‐on‐Chip Platform to Study Off‐Target Cardiotoxicity of Drugs Upon Liver Metabolism
    Erika Ferrari, Roberta Visone, Elisa Monti, Enrica Torretta, Matteo Moretti, Paola Occhetta, Marco Rasponi · 2023 · Advanced Materials Technologies
  80. Artificial Intelligence, Machine Learning, and Big Data for Ebola Virus Drug Discovery
    Samuel K. Kwofie, Joseph Adams, Emmanuel Broni, Kweku S. Enninful, Clement Agoni, Mahmoud E. S. Soliman, Michael D. Wilson · 2023 · Pharmaceuticals
  81. Magnetic self-assembly of 3D multicellular microscaffolds: A biomimetic brain tumor-on-a-chip for drug delivery and selectivity testing
    Attilio Marino, Matteo Battaglini, Alessio Carmignani, Francesca Pignatelli, Daniele De Pasquale, Omar Tricinci, Gianni Ciofani · 2023 · APL Bioengineering
  82. Interaction of Epigallocatechin Gallate and Quercetin with Spike Glycoprotein (S-Glycoprotein) of SARS-CoV-2: In Silico Study
    Mehran Alavi, Mohammad Reza Mozafari, Saba Ghaemi, Morahem Ashengroph, Fatemeh Hasanzadeh Davarani, Mohammadreza Mohammadabadi · 2022 · Biomedicines
  83. Preclinical Testing Techniques: Paving the Way for New Oncology Screening Approaches
    Antonia van Rijt, Evan Stefanek, Karolina Papera Valente · 2023 · Cancers
  84. Artificial intelligence in parasitic disease control: A paradigm shift in health care
    Subhash Chandra Parija, Abhijit Poddar · 2024 · Tropical parasitology
  85. Microfluidic platforms for monitoring cardiomyocyte electromechanical activity
    Wei Wang, Weiguang Su, Junlei Han, Wei Song, Xinyu Li, Chonghai Xu, Yu Sun, Li Wang · 2025 · Microsystems & Nanoengineering
  86. Nanomaterial-assisted CRISPR gene-engineering – A hallmark for triple-negative breast cancer therapeutics advancement
    Jabeen Farheen, Narayan S. Hosmane, Ruibo Zhao, Qingwei David Zhao, M. Zubair Iqbal, Xiangdong Kong · 2022 · Materials Today Bio
  87. Explore drug-like space with deep generative models
    Jianmin Wang, Jiashun Mao, Meng Wang, Xiangyang Le, Yunyun Wang · 2023 · Methods
  88. CRISPR-phage antibacterials to address the antibiotic resistance crisis: scientific, economic, and regulatory considerations
    Danielle M. Pacia, Beatrice L. Brown, Timo Minssen, Jonathan J. Darrow · 2024 · Journal of Law and the Biosciences
  89. Databases of ligand-binding pockets and protein-ligand interactions
    Kristy A. Carpenter, Russ Biagio Altman · 2024 · Computational and Structural Biotechnology Journal
  90. Fighting Cancer with Photodynamic Therapy and Nanotechnologies: Current Challenges and Future Directions
    Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher · 2025 · International Journal of Molecular Sciences
  91. Intelligent nanoparticle design: Unlocking the potential of AI for transformative drug delivery
    Sepinoud Azimi · 2025 · Current Opinion in Biomedical Engineering
  92. Targeting mitochondrial transporters and metabolic reprogramming for disease treatment
    Mboneye Anselme, Huafeng He, Chengyang Lai, Wenwei Luo, Shilong Zhong · 2025 · Journal of Translational Medicine
  93. Alternatives to animal testing are the future — it’s time that journals, funders and scientists embrace them
    Todd J. Herron, Anke Brüning‐Richardson, Julie Elizabeth Gough, Aline F. Miller, Geoffrey John Pilkington, John Greenman, Valerie Speirs, Joseph C. Wu · 2025 · Nature
  94. Towards a gold standard functional readout to characterize In Vitro lung barriers
    Ali Doryab, Otmar Schmid · 2022 · European Journal of Pharmaceutical Sciences
  95. Applications of machine learning in microbial natural product drug discovery
    Autumn Arnold, Jeremie Alexander, Gary Liu, Jonathan M. Stokes · 2023 · Expert Opinion on Drug Discovery
  96. Progress of AI-Driven Drug–Target Interaction Prediction and Lead Optimization
    Qiqi Wang, Boyan Sun, Yunpeng Yi, Tony Velkov, Jianzhong Shen, Chongshan Dai, Haiyang Jiang · 2025 · International Journal of Molecular Sciences
  97. Microfluidic Droplet-Assisted Fabrication of Vessel-Supported Tumors for Preclinical Drug Discovery
    Yue Wu, Yuwen Zhao, Yuyuan Zhou, Khayrul Islam, Yaling Liu · 2023 · ACS Applied Materials & Interfaces
  98. A Benchmark Study of Graph Models for Molecular Acute Toxicity Prediction
    Rajas Ketkar, Yue Liu, Hengji Wang, Hao Tian · 2023 · International Journal of Molecular Sciences
  99. Prioritising genetic findings for drug target identification and validation
    Nikita Hukerikar, Aroon Dinesh Hingorani, Folkert Wouter Asselbergs, Chris Finan, Amand Floriaan Schmidt · 2024 · Atherosclerosis
  100. Exploring acetaminophen prodrugs and hybrids: a review
    Vladímir V. Kouznetsov · 2024 · RSC Advances